Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F2 | P00734 | 10/20 | 0.38 |
| ▸ | F10 | P00742 | 7/20 | 0.38 |
| ▸ | PLG | P00747 | 3/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.30 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7418083 | 0.95 | F2 (0.41) | F2F10PLGALDH1A1GAA | |
| SCHEMBL7488072 | 0.91 | F2 (0.39) | F2F10PLGALDH1A1GAA | |
| SCHEMBL7415568 | 0.91 | F2 (0.38) | F2F10PLGALDH1A1GAA | |
| SCHEMBL7413417 | 0.90 | F2 (0.41) | F2F10PLGALDH1A1GAA | |
| SCHEMBL7412758 | 0.90 | F2 (0.38) | F2F10PLGALDH1A1GAA | |
| SCHEMBL7413698 | 0.90 | F2 (0.39) | F2F10PLGALDH1A1 | |
| SCHEMBL7413541 | 0.90 | F2 (0.38) | F2F10PLGALDH1A1GAA | |
| SCHEMBL7416844 | 0.90 | F2 (0.39) | F2F10PLGALDH1A1GAA | |
| SCHEMBL7413828 | 0.87 | F2 (0.37) | F2F10PLGALDH1A1MAPT | |
| SCHEMBL7411436 | 0.86 | F2 (0.38) | F2F10PLGSIRT2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1095025-B1 | BENZIMIDAZOLES, PRODUCTION THEREOF AND USE THEREOF AS MEDICAMENTS | BOEHRINGER INGELHEIM PHARMA (DE) | 2002-12-11 | — | — | EP | disclosed |
| US-6248770-B1 | CARDIOVASCULAR DISORDERS | BOEHRINGER INGELHEIM PHARMA KG (DE) | 2001-06-19 | — | — | US | disclosed |